Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: CAPEOX ×

CAPEOX

This drug is selected. Its supporting articles are shown below.

Articles mentioning CAPEOX

3 articles · page 1 of 1

Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol

bmjopen · abstract · 2025-09-26 · 3 matching annotations

95.9%

Fruquintinib sintilimab CAPEOX oxaliplatin capecitabine chemotherapy immunotherapy

…cer, although there remains a need for improvement in efficacy. Fruquintinib, an oral and highly selective vascular endothelial growth facto…

CapeOX (capecitabine and oxaliplatin) combined with sintilimab and bevacizumab biosimilar (IBI305) for first-line treatment of advanced gastric or oesophagogastric junction adenocarcinoma: study protocol for a single-arm, phase Ib/II trial

bmjopen · abstract · 2026-01-09 · 2 matching annotations

94.7%

IBI305 sintilimab capecitabine CapeOX oxaliplatin bevacizumab gastric or gastro-oesophageal junction (G/GEJ) cancer chemotherapy G/GEJ

…, the patients will receive CapeOX combined with sintilimab and IBI305 at the recommended phase II dose. The primary objectives will b…

Retroperitoneal mature teratoma with malignant transformation to colorectal phenotype adenocarcinoma and ovarian metastasis

bmjcr · abstract · 2026-06-26 · 1 matching annotations

75.1%

capecitabine oxaliplatin CAPEOX Retroperitoneal teratomas squamous cell carcinoma colonic-type adenocarcinoma Adenocarcinoma of colorectal phenotype

…eft nephrectomy and lymph node dissection, followed by adjuvant capecitabine plus oxaliplatin (CAPEOX) chemotherapy. Six months later, she d…